Characteristics and outcomes of young patients with ST segment elevation myocardial infarction undergoing primary

Benjamin Wl Tung1,2, Zhe Yan Ng3, William Kristanto3,4

  • 1Cardiology, National University Heart Centre, Singapore benjamin_wl_tung@nuhs.edu.sg.

Open Heart
|January 14, 2021
PubMed

Insights

Young patients experiencing ST segment elevation myocardial infarction (STEMI) have distinct risk factors and lower mortality than older patients. Public health initiatives should target these factors to reduce STEMI burden in younger populations.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • ST segment elevation myocardial infarction (STEMI) significantly impacts life years, particularly in younger individuals.
  • Primary percutaneous coronary intervention (PPCI) is a key treatment for STEMI.

Purpose of the Study:

  • To compare characteristics and outcomes of young (<50 years) versus older (≥50 years) STEMI patients undergoing PPCI.
  • To inform public health strategies for STEMI prevention.

Main Methods:

  • Retrospective review of the Coronary Care Unit database at National University Hospital, Singapore (July 2015 - June 2019).
  • Patients were stratified into young (<50 years) and older (≥50 years) groups.

Main Results:

  • Of 1818 STEMI patients undergoing PPCI, 25.6% were <50 years old.
  • Young STEMI patients were more likely male, current smokers, of Indian ethnicity, with a family history of ischaemic heart disease (IHD).
  • One-year mortality was lower in young patients (3.4%) vs. older patients (10.4%, p<0.0001). Age predicted mortality in older patients; diabetes showed a trend in both groups.

Conclusions:

  • Young STEMI patients present with specific risk factors including smoking, Indian ethnicity, and family history of IHD, alongside prevalent cardiometabolic risks.
  • While mortality is lower in younger STEMI patients, it is not insignificant, necessitating targeted public health interventions.
  • Reducing the prevalence of identified risk factors in susceptible young populations is crucial for STEMI prevention.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
297
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
93
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
96
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
137
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
125
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
530